Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Prolactin in multiple sclerosis.
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Features of sleep disturbances in multiple sclerosis patients.
A pervasive assessment of motor function: a lightweight grip strength tracking system.
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis.
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.
Managing treatment fatigue in patients with multiple sclerosis on long-term therapy: the role of multiple sclerosis nurses.
Multiple Sclerosis: Does Nogo Play a Role?
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis, AIDS, and multiple sclerosis.
Central nervous system B-cell lymphoma in multiple sclerosis.
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
A wireless body measurement system to study fatigue in multiple sclerosis.
[Retinal vasculitis as manifestation of multiple sclerosis.]
Proteomic analysis of the cerebrospinal fluid in multiple sclerosis and neuromyelitis optica patients.
Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
Insight towards the conserved water mediated recognition of catalytic and structural Zn(+2) ions in human Matrix Metalloproteinase-8 enzyme: A study by MD-simulation methods.
Endogenous GABA controls oligodendrocyte lineage cell number, myelination, and CNS internode length.
Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis.
Pages
« first
‹ previous
…
255
256
257
258
259
260
261
262
263
…
next ›
last »